J Am Acad Dermatol. 2018 Feb;78(2):419-421. doi: 10.1016/j.jaad.2017.07.059.

Predicting the incidence and timing of central nervous system disease in metastatic melanoma: Implications for surveillance and preventative therapy.

1: Hofstra-Northwell School of Medicine Uniondale, New York, New York. Electronic address: gdeutsch@northwell.edu.
2: Hofstra-Northwell School of Medicine Uniondale, New York, New York.
3: Brain Tumor Center, New York, New York.
4: Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York.
5: Donald L. Morton, MD, Melanoma Research Program, New York, New York.